SIGLEC15 and non-Hodgkin lymphoma: We reported that down-regulation of CHIT1, SIGLEC15, PLA2G2D and TMEM163 was associated with poor prognosis in immunocompetent NHL, and expression levels of four genes were lower in lymphoma than in normal tissues.